Cargando…
Effect of Thiol-reducing Agents and Antioxidants on Sulfasalazine-induced Hepatic Injury in Normotermic Recirculating Isolated Perfused Rat Liver
Sulfasalzine is a widely administered drug against inflammatory-based disorders in human. However several cases of liver injury are associated with its administration. There is no stabilized safe protective agent against sulfasalazine-induced liver injury. Current investigation was designed to evalu...
Autores principales: | Heidari, Reza, Esmailie, Neda, Azarpira, Negar, Najibi, Asma, Niknahad, Hossein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Toxicology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843982/ https://www.ncbi.nlm.nih.gov/pubmed/27123164 http://dx.doi.org/10.5487/TR.2016.32.2.133 |
Ejemplares similares
-
Sulfasalazine-induced renal and hepatic injury in rats and the protective role of taurine
por: Heidari, Reza, et al.
Publicado: (2016) -
Sulfasalazine induces mitochondrial dysfunction and renal injury
por: Niknahad, Hossein, et al.
Publicado: (2017) -
Oral administration of thiol-reducing agents mitigates gut barrier disintegrity and bacterial lipopolysaccharide translocation in a rat model of biliary obstruction
por: Ommati, Mohammad Mehdi, et al.
Publicado: (2020) -
Taurine mitigates cirrhosis-associated heart injury through mitochondrial-dependent and antioxidative mechanisms
por: Mousavi, Khadijeh, et al.
Publicado: (2020) -
Pentoxifylline mitigates cholestasis-related cholemic nephropathy
por: Ommati, Mohammad Mehdi, et al.
Publicado: (2021)